How it All Began
The company was founded in 1998 by our Chairman and Executive Director Dr. Zhaohua Chang. However the MicroPort® story and the motivation for our unique development begins in 1995, when the Shanghai Municipal Government invited a group of leading globally accomplished Chinese scholar's based internationally to form a delegation to visit Shanghai. Back then Dr. Chang was a highly successful and respected leading research scientist working in some of the best scientific institutions, companies and Universities in the USA.
Returning to China as a visiting delegate provided the initial spark of inspiration. Dr. Chang witnessed, after years living abroad, the remarkable and rapid changes facing his homeland. Knowing that China's device sector was completely dependent on expensive imported technology and was extremely disadvantaged in terms of it's capabilities for independent research and development, Dr. Chang determined to do something concrete to change the future.
So during this brief visit to Shanghai in 1995 the history of MicroPort® began when Dr. Chang decided it was time to return home and bring his scientific expertise back to China for the benefit of the Chinese people. Three years later Dr. Chang had set about developing a uniquely Chinese business to provide a home in China for likeminded scientists, and MicroPort® was born.
An academic scholar and scientist with a passion for bioengineering and some good ideas, made a significant contribution to the establishment of high-tech medical device development and manufacturer in China. This is where our company history begins.
Those early years were tough and the company faced many difficulties. At times it seemed an impossible dream and it appeared events conspired to frustrate and undermine the company just as it was beginning to establish a foundation.
Fortunately, our founder was steadfast in his own confidence and determination to create a different kind of company. It was his perseverance to gather together what he often refers to as the 'dream team' of leadership and scientists that enabled the realisation of his original vision.
MPSC was listed in the Shenzhen-Hong Kong Stock Connect
"New Technology and Clinical Application of Minimally Invasive Cardiac Surgery" Project Won the Second Prize of State Science and Technology Progress Award
"Key technology and industrialization platform for minimally invasive interventional and implantable medical devices" project won prestigious class II prize of State Science and Technology Advancement Award
MicroPort® EP Columbus® 3D EP Navigation System received the CFDA registration certificate
MicroPort® Online network service platform "Life Line Live" was officially launched
MicroPort® was awarded Five Star Credit Enterprise
Firehawk™ Rapamycin Target Eluting Coronary Stent received CE Mark certificate
WILLIS™ clinical application project won prestigious class II prize of State Science and Technology Advancement Award
EVOLUTION™ medial-pivot knee system received CFDA approval
MicroPort Sorin CRM (Shanghai) Co., Ltd. launched China's first domestic pacemaker production line
Shanghai MicroPort Orthopedics Co., Ltd. moved to new headquarters in Suzhou
MicroPort Suzhou OrthoRecon Co., Ltd. and MicroPort Suzhou Orthopedic Instruments Co., Ltd. were established in Suzhou Industrial Zone
MicroPort Surgical Robotics Co., Ltd. and MicroPort Online Co., Ltd. were established
Liangzhi Creative Center and Knowledge & Action Center at corporate HQ were officially put into use
Shanghai MicroPort EP MedTech Co., Ltd. successfully completed restructuring
Shanghai MicroPort EP MedTech Co., Ltd. received "Shanghai Hi-Tech Enterprise" honor
Signed joint venture agreement with Sorin Group for China's cardiac rhythm management business
Completed acquisition of Wright Medical's OrthoRecon business
Acquired drug eluting stent related assets and intellectual properties from Cordis
Firehawk™ rapamycin target eluting coronary stent system received CFDA approval
Corporate headquarters relocated to 1601 Zhangdong Rd at completed industrialization base in Zhangjiang Riverfront harbor
Established MPSC Research & Engineering Academy
WILLIS™ intracranial stent graft system received SFDA approval
Construction began on Suzhou orthopedic industrial base
Acquired Wright Medical's OrthoRecon Business for $290 Million
Shanghai MicroPort EP MedTech Co., Ltd.'s FireMagic™, EasyFinder™, EasyLoop™ and FireMagic™ 3D and Columbus™ received CE mark certificates
Initiated "United Fleets of MicroPort®" operating model
Shanghai D-Pulse Medical Co., Ltd. was established in Shanghai International Medical Zone
Shanghai MicroPort NeuroTech Co., Ltd. and MicroPort Surgical (Shanghai) Co., Ltd. were established in Shanghai International Medical Zone
Total tax contribution reached 1 billion RMB
Acquired D-Pulse Medical (Beijing) Co., Ltd. and Dongguan Kewei Medical Instrument Co., Ltd.
MicroPort Orthopedics (Suzhou) Co., Ltd. was established in Suzhou Industrial Park
MicroPort Medical (Shanghai) Co., Ltd. was renamed Shanghai MicroPort Medical (Group) Co., Ltd.
MicroPort International Corp. Ltd. was established in Hong Kong
Shanghai MicroPort Orthopedics Co., Ltd. acquired Suzhou Best Co., Ltd.
Coronary drug eluting stent implants reached over 700,000 units
Undertook national R&D projects accumulating to more than 100 million RMB
MicroPort Medical (Jiaxing) Co., Ltd. was established in Jiaxing Science City
Shanghai MicroPort EP MedTech Co., Ltd. was established in Shanghai International Medical Zone
MicroPort Scientific Corporation listed on Hong Kong Stock Exchange (00853.HK)
Annual sales exceeded 100 million USD
Shanghai MicroPort Orthopedics Co., Ltd. was established in Shanghai International Medical Zone
FireMagic™ ablation catheter received SFDA approval
Construction of a new industrialization base began in Zhangjiang Riverfront Harbor
Received 54.3 million RMB from Shanghai municipal government to develop and enhance industrial capacity in minimally invasive medicine
Shanghai MicroPort Lifesciences Co, Ltd. was established at the Shanghai International Medical Zone
Officially entered diabetes business with acquisition of Beijing PanGeRui Medical Device Company
Firebird2™ coronary drug eluting stent system received SFDA approval
Began experimental implementation of "Vertical Integration & Horizontal Connection" management concept
Firebird™ coronary drug eluting stent system won prestigious class II prize of State Science and Technology Advancement Award
Coronary drug eluting stent implants reached over 100,000 units
MicroPort Scientific Corporation was established
Entered Latin American market with successful auditing by ANMAT of Argentina
Firebird™ drug eluting stent system was named Shanghai's key new product
Annual sales exceeded 100 million RMB
Firebird™ drug eluting stent system received SFDA approval
Mustang™ coronary stent system received CE mark certificate
Officially entered international market with PTCA Balloon dilatation catheters by receiving import license from Ministry of Health, Labor and Welfare of Japan
Received major funding from National Development and Reform Commission
Moved into new headquarters at 501 Newton Road, Zhangjiang Hi-Tech Park
Received "Shanghai Hi-Tech Enterprise" honor and business became profitable
Mustang™ bare metal stent received SFDA approval
PTCA balloon dilatation catheter received SFDA approval, very first sale made
Founded on May 15, 1998 at an incubation center in Zhangjiang Hi-Tech Park, Shanghai